ACTIVE

AKSA PHARMA

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
-54,1 k €
-135.0% YoY
Gross margin
174 k €
-60.3% YoY
Equity
156,6 k €
-25.7% YoY
Workforce
3,6 ETP
+20.0% YoY

What does AKSA PHARMA do?

AKSA PHARMA is a Private limited company incorporated in 2016. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles. It employs on average 3,6 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0651.787.243
Incorporation
11/04/2016
Legal form
Private limited company
Registered office
Avenue de l'Araucaria 79
1020 Bruxelles · BruxellesSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Average workforce
3,6 ETP
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores
Joint committees (2)
  • 313
  • 330
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 8 financial years

20242023202220212020201920182017
Income statement
Gross margin174 k €438,3 k €375,8 k €250,2 k €139,4 k €-51,2 k €20,6 k €2,8 k €
EBITDA-11,4 k €254,7 k €228,8 k €121,3 k €7,1 k €-110,8 k €-8 k €2,8 k €
Operating result-40,4 k €224,5 k €198,5 k €83,6 k €-30,4 k €-147,7 k €-10,9 k €-5,2 k €
Net result-54,1 k €154,5 k €168,4 k €74,3 k €-36,9 k €-150 k €-11,9 k €-6,3 k €
Balance sheet
Equity156,6 k €210,7 k €56,1 k €-112,3 k €-186,6 k €-149,7 k €377,9 €12,3 k €
Total assets524,3 k €627,8 k €645,3 k €577,4 k €618,2 k €639,7 k €40,3 k €61,4 k €
Cash1,4 k €50 k €120 k €50 k €71,8 k €87,2 k €3,6 k €8,4 k €
Debts367,6 k €417,1 k €589,1 k €689,7 k €804,8 k €789,4 k €39,9 k €49,1 k €
Other
Workforce3,6 ETP3,0 ETP3,0 ETP–––––
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

RICHARD BONTEMPS

Administrator - manager

Active

Ended mandates

RICHARD BONTEMPS

Manager · since 04 juillet 2018

Ended
KHEMAIS BEN SASSI

Manager · since 06 avril 2016

Ended
RICHARD BONTEMPS

Director

Ended
RICHARD BONTEMPS

Manager

Ended
At this address

Other companies at this address

CompanyCBE no.
CENTRE MEDICAL ARAUCARIA● Active
0779.908.308
GynSeno Med● Active
1040.123.674
Institut de la Femme et du Fœtus● Active
1040.806.535
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202601/09/202405/09/202314/09/202220/09/202127/11/2020
General meeting05/06/202531/07/202401/06/202302/06/202203/06/202104/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

8 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202405/06/202523/06/2026FrenchPDF
Abridged model31/12/202331/07/202401/09/2024FrenchPDF
Abridged model31/12/202201/06/202305/09/2023FrenchPDF
Micro model31/12/202102/06/202214/09/2022FrenchPDF
Micro model31/12/202003/06/202120/09/2021FrenchPDF
Micro model31/12/201904/06/202027/11/2020FrenchPDF
Micro model31/12/201806/06/201907/08/2019FrenchPDF
Micro model31/12/201707/06/201827/06/2018FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

RICHARD BONTEMPS

Administrator - manager

Active

Ended mandates

RICHARD BONTEMPS

Manager · since 04 juillet 2018

Ended
KHEMAIS BEN SASSI

Manager · since 06 avril 2016

Ended
RICHARD BONTEMPS

Director

Ended
RICHARD BONTEMPS

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office03/11/2025
    SIEGE SOCIAL
    PDF
  • Mandates17/11/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office27/04/2020
    SIEGE SOCIAL
    PDF
  • Mandates10/08/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Other13/04/2016
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-54,1 k €↓
  2. 2023
    Annual accounts 2023154,5 k €↓
  3. 2022
    Annual accounts 2022168,4 k €↑
  4. 2021
    Annual accounts 202174,3 k €↑
  5. 2021
    Name changeAKSA
  6. 2020
    Annual accounts 2020-36,9 k €↑
  7. 2019
    Annual accounts 2019-150 k €↓
  8. 2018
    Annual accounts 2018-11,9 k €↓
  9. 2017
    Annual accounts 2017-6,3 k €
  10. 2017
    Name changeAKSA PHARMA
  11. 11/04/2016
    IncorporationPrivate limited company